Showing results (961-970 of 2,578) with videos related to
Sort By:
Pageof 258
Molecular Oncology|March 17, 2020
Specific requirements for translation of biological research into clinical radiation oncologyMechthild Krause, Jan Alsner, Annett Linge, et al.Molecular Oncology|March 3, 2020
Programmed death-ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21-gene and 70-gene signatures in estrogen receptor-positive diseaseIoannis Zerdes, Emmanouil G Sifakis, Alexios Matikas, et al.Molecular Oncology|March 4, 2020
Technology-driven research for radiotherapy innovationClaudio Fiorino, Matthias Guckemberger, Marco Schwarz, et al.Molecular Oncology|March 20, 2020
Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterationsAtsuko Ogino, Jihyun Choi, Mika Lin, et al.Molecular Oncology|March 19, 2020
Concordance between TP53 alterations in blood and tissue: impact of time interval, biopsy site, cancer type and circulating tumor DNA burdenCheyennedra C Bieg-Bourne, Ryosuke Okamura, Razelle KurzrockMolecular Oncology|January 4, 2020
A SIRPα-Fc fusion protein enhances the antitumor effect of oncolytic adenovirus against ovarian cancerYao Huang, Sai-Qun Lv, Pin-Yi Liu, et al.Molecular Oncology|April 3, 2020
Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1Duoguang Wu, Xiaotian He, Wenjian Wang, et al.Molecular Oncology|September 23, 2020
Climate change and cancer: converging policiesPaolo Vineis, Inge Huybrechts, Christopher Millett, et al.Molecular Oncology|September 24, 2020
Behavioural and structural interventions in cancer prevention: towards the 2030 SDG horizonJose M Martin-Moreno, Natalia Ruiz-Segovia, Eduardo Diaz-RubioMolecular Oncology|September 19, 2020
Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patientsPauline A J Mendelaar, Jaco Kraan, Mai Van, et al.Pageof 258